KELLY MERCHIE: Open Payments
NPI 1265048870 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,779 in 77 payments from 21 companies in 2025. Trend: 2023 $5,166 · 2024 $3,621 · 2025 $1,779
Food & beverage: $1,720Education: $58
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $419 |
| Eisai Inc. | 19 | $402 |
| ARGENX US, INC. | 3 | $145 |
| Teva Pharmaceuticals USA, Inc. | 4 | $109 |
| Lilly USA, LLC | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Lundbeck LLC | 3 | $62 |
| ACADIA Pharmaceuticals Inc | 3 | $58 |
| Amneal Pharmaceuticals LLC | 2 | $51 |
Products named: Leqembi, QULIPTA, VYALEV, VYVGART, REXULTI, KISUNLA, UBRELVY, KESIMPTA.
Industry payments across IA — which companies pay providers there.
